Shifts in sugar consumption in Canada uncovered

Public health researchers and organizations have increasingly warned that high sugar consumption can lead to the development of several metabolic and cardiovascular diseases. A new study released by Statistics Canada this month asks whether Canadians

Proteon Therapeutics Announces Publication of Results from Phase 3 PATENCY-1 Clinical Trial of Investigational Vonapanitase in Patients with Chronic Kidney Disease

WALTHAM, Mass., Jan. 24, 2019 (GLOBE NEWSWIRE) — Proteon Therapeutics Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with kidney and vascular diseases, today announced the publication